Relmada Therapeutics (RLMD) Gross Profit (2012 - 2013)
Relmada Therapeutics' Gross Profit was $1,093 in FY2013, down 49.0% from $2,142 in FY2012.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Gross Profit (2012 - 2013) Analysis & Trends
- Per Business Quant data, Gross Profit in earlier years was $2,142 in FY2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Relmada Therapeutics | 361.29 Mn | -197.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2013 | 164.00 |
| May 31, 2013 | 312.00 |
| Feb 28, 2013 | 482.00 |
| Nov 30, 2012 | 299.00 |
| Aug 31, 2012 | 517.00 |
| May 31, 2012 | 108.00 |
API Access
Relmada Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();